Stock HRTIS HERANTIS PHARMA OYJ
Add to a list
To use this feature you must be a member
Log inSign up

All News Herantis Pharma Oyj

Equities

HRTIS

FI4000087861

Delayed Nasdaq Helsinki
Other stock markets
 14:50:00 02/07/2024 BST 		5-day change 1st Jan Change
1.695 EUR +5.28% Intraday chart for Herantis Pharma Oyj +3.35% +7.62%
05-20 Herantis Pharma Submits Clinical Trial Application for A Phase 1B Clinical Trial of Her-096 CI
03-06 Herantis Pharma Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Herantis Pharma Submits Clinical Trial Application for A Phase 1B Clinical Trial of Her-096
CI
Herantis Pharma Oyj Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Transcript : Herantis Pharma Oyj, 2023 Earnings Call, Mar 06, 2024
Herantis Pharma Oyj: Managers' Transactions – Tone Kvåle
AQ
Herantis Pharma Oyj : Minutes of Herantis Pharma Plc’s extraordinary general meeting of shareholders November 17, 2023
PU
Herantis Pharma Oyj : Notice to Convene Herantis Pharma Plc's Extraordinary General Meeting of Shareholders November 17, 2023
PU
Transcript : Herantis Pharma Oyj - Special Call
Herantis Pharma's Early-stage Study of Parkinson's Therapy Shows Positive Data; Stock Surges
MT
Herantis Pharma Plc Announces Positive Topline Data from Phase 1a Clinical Trial of HER-096
CI
Herantis Pharma Secures EUR4.5 Million Loan Waive-off From Business Finland
MT
Transcript : Herantis Pharma Oyj, H1 2023 Earnings Call, Aug 24, 2023
Herantis Pharma Oyj Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Herantis Pharma plc Announces First Healthy Volunteers Dosed in the Part 2 of the Her-096 Phase 1A Clinical Study
CI
Herantis Pharma Plc's shares subscribed with option rights
AQ
Herantis Pharma Plc announcing start of recruitment of healthy volunteers for part 2 of the ongoing Phase 1a clinical study of HER-096
AQ
Herantis Pharma Plc Announces Start of Recruitment of Healthy Volunteers for Part 2 of the Ongoing Phase 1a Clinical Study of HER-096
CI
Herantis Pharma Oyj: Managers' Transactions - Aki Prihti
AQ
Herantis Pharma Oyj: Managers' Transactions - Timo Veromaa
AQ
Herantis Pharma Oyj: Managers' Transactions - Frans Wuite
AQ
Herantis Pharma Oyj: Managers' Transactions - Tone Kvåle
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HRTIS Stock
  4. News Herantis Pharma Oyj